L-Ornithine-L-Aspartate
Insulin (antidiabetic hormone)
What it is used for
High ammonia levels; severe liver impairment; end-stage cirrhosis Clinical selection for L-Ornithine-L-Aspartate should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Insulin (antidiabetic hormone). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
HIGH-ALERT medication. Dose double-checks. Educate hypo recognition/treatment. Adjust for renal failure (reduced clearance), illness, steroids, exercise. Never share pens. Rotate sites.
Possible side effects
Hypoglycaemia, weight gain, injection-site reactions, lipodystrophy. Rare: severe allergy, hypokalaemia (shift).
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.